TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-Efficacy for Parenting Tasks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Well child care engagement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Parenting Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal-child interaction quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to hematopoietic recovery post chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients taking RAASi for clear prognostic indications with changes due to hyperkalaemia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients taking RAASi without clear prognostic indications with changes due to hyperkalaemia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in behavioral writing measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in brain connectivity in the motor network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Breath records
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gait adaptability capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of the head-mounted device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: INVICTA lead electrical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Definitive diagnosis of IBMFS-RD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline skin carotenoid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants Who Disclosed the Donor Conception to Their Children
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Proportion of patients with tumor resectability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Voice Quality of Life as measured by the Voice Related Quality of Life - 10
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Swallowing Quality of Life as assessed by the Eating Assessment Tool - 10
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scar Quality as assessed by The Patient and Observer Scar Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POMI scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Molecular changes in the bronchial epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Performance Category at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Percentage of Circulating T Regulatory Cells (Treg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of correctly identified targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Newborn Growth and Physiologic Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival rate (6mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Resting-state electroencephalogram (EEG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalogram (EEG) event-related potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subclavian Vein Collapsibility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inferior Vena Cava Collapsibility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hypotension after induction of General anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success rate of TceMEPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Shoulder Pain and Disability Index (SPADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lempel Ziv complexity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UV amplitude in MSEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: latency in MSEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants with Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Facial expression recognition task (FERT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Visual Analogue Scale (VAS Score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Youth Inventory of Involvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ASSR Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole word accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of SARS-CoV-2 Specific Neutralizing Antibody (nAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Titer (GMT) of SARS-CoV-2 Specific Binding Antibody (bAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Seroresponse Against SARS-CoV-2 Omicron Variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients maintaining Hct without phlebotomy eligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients maintaining steroid-free clinical and biological remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMSE reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day mortality after onset
Endpoint domain: Mortality/survival
Primary endpoint: Number of subjects who experience Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects who experience specific treatment-related adverse events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Determination of the Maximum Tolerated Dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in coaches' self-efficacy in body image
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tumor Mutation Burden (TMB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of subjects with mRS ≤ 2 at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Home cooking habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Home cooking attitudes and self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety assessment 30 minutes before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average serum CNN2 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission by central read Mayo score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hippocampal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in hyperacusis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalised Anxiety Disorder (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Therapy (DOT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Next Therapy (TTNT)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Lactate During Exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-traumatic injuries of the ligaments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Passive Knee Extension Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of high-risk pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Frequency of quit attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of Cigarettes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nicotine dependence severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time profile (AUClast, AUCinf) of sublingual minoxidil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration (Cmax) of sublingual minoxidil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of maximum observed concentration (Tmax) of sublingual minoxidil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants that use HIV services while incarcerated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants that use of PrEP if HIV negative
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants that have HIV testing in the community if unknown status during incarceration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: modulation of liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Toll like receptor - 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiovascular death, non-fatal myocardial infarction or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Rate of grade 2 or higher acute toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Drug Limiting Toxicities (DLT) in Stratum 1
Endpoint domain: Adverse events/effects
Primary endpoint: Drug Limiting Toxicities (DLT) in Stratum 2
Endpoint domain: Adverse events/effects
Primary endpoint: CIVIQ-2 score changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tinnitus relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ArmA inter-rater reproducibility values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in volume of intracerebral hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mouth opening distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bruxism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: limitation of the movement of the temporomandibular joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician action rating
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Preoperative blood glucose 30min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative blood glucose 30min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain score during and after arterial blood sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embryonic model performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gamete model performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometrial model performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embryonic model clinical efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometrial model clinical efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post exposure pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical assessment of Proximal Contact Points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographically Assessment of proximal overhangs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of patient comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Electromyographic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise-induced hypoalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the trans-femoral approach
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Fat Oxidation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of bleeding free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular Mobility Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Post prandial 2 hour circulating blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Beverage Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary Stress Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants with treatment related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Early Adverse Events/toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with peripheral arterial oxygen saturation below 93%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of numerical simulation for stent deployment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of SY-2101
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve (AUC) of SY-2101
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in COVID-19 viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Normalization of fever, respiratory rate, oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hospitalization / recovery time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Liver elastography by MRE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Liver elastography by T1rho
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Heart tissue characterization by T1 mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart tissue characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of acute gastro-intestinal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: internet addiction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Results of bladder exstrophy repair technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Least Squares Mean Distance Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved spirometry tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Omics differences of blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Omics differences of urine samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: peritoneal transport rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Documented Counseling on Transitions of Care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: User experience of patients (AttrakDiff)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: User experience of patients (meCUE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of cluster headache attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Women Who Undergo Cervical Cancer Screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Practice Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Cannabis Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health Status Questionnaire (Short Form-SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short Form 12-Item (SF-12) Health Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attainment of developmental milestones and any regressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wear resistance of denture artificial teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surface hardness of the denture artificial teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra organ sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goniometric measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IgG/IgM Antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adipose tissue macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Body fat %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predicated maximal oxygen uptake (MaxVO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-Repetition Maximum Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in International Paediatric Mitochondrial Disease Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-Day Mortality
Endpoint domain: Mortality/survival
Primary endpoint: In-Hospital Cardiac Arrest (IHCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unplanned Admission to the Intensive Care Unit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Relative-Dose-Intensity (RDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sexual Health Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Composite Executive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participant Acceptability Ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asthma-related emergency department (ED) utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: improved endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improved quality of night sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reducing the degree of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: qEEG session data analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in number of migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspiration Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody levels of the viral spike protein 4 weeks after second vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody levels of the viral spike protein 3 months after second vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes